CPC C07D 417/12 (2013.01) [A61P 1/00 (2018.01); C07D 417/14 (2013.01)] | 8 Claims |
1. A compound represented by Formula 1 below, a stereoisomer thereof or a pharmaceutically acceptable salt thereof:
wherein, A is hydrogen, halogen, a hydroxyl group, a C1-C3 alkyl group, a C2-C3 alkenyl group, a C2-C3 alkynyl group, a C1-C3 alkoxy group, dimethylamine, —NO2, —CN, —COOR2 or —S(═O)2R2,
B is hydrogen, a C1-C3 alkyl group, a phenyl group, an acetyl group, —CH2C(═O)OR2, —C(═O)OR2 or —S(═O)2R2,
R1 is a substituted or unsubstituted 5-7 membered heterocyclic ring or —NH2, and
A R2 is a C1-C3 alkyl group.
|